Subscribe
shutterstock_1113551483_sharafmaksumov
sharafmaksumov / Shutterstock.com
12 February 2019Americas

Clarivate announces new Life Science Alliances programme

Global information company  Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Seven new drugs to join $1bn club by 2021, says Clarivate
21 March 2019   Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
Seven new drugs to join $1bn club by 2021, says Clarivate
21 March 2019   Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report.

More on this story

Big Pharma
Seven new drugs to join $1bn club by 2021, says Clarivate
21 March 2019   Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York